AGNPF - Seyltx acquires Algernon's Chronic Cough Research Program for $2M and 20% stake
2023-11-22 07:35:34 ET
More on Algernon Pharmaceuticals
For further details see:
Seyltx acquires Algernon's Chronic Cough Research Program for $2M and 20% stakeLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
home / news releases / AGNPF - Seyltx acquires Algernon's Chronic Cough Research Program for $2M and 20% stake
Stock Information
| Company Name: | Algernon Pharmaceuticals Inc - Class A |
| Stock Symbol: | AGNPF |
| Market: | OTC |
| Website: | algernonpharmaceuticals.com |
Get AGNPF Alerts
News, Short Squeeze, Breakout and More Instantly...